An International Prognostic Calculator for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Relapsed/Refractory International Prognostic Index (R/R-IPI): An International Prognostic Calculator for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Am. J. Hematol 2021 Mar 04;[EPub Ahead of Print], MJ Maurer, LH Jakobsen, R Mwangi, N Schmitz, U Farooq, CR Flowers, P de Nully Brown, CA Thompson, H Frederiksen, D Cunningham, J Jørgensen, V Poeschel, G Nowakowski, JF Seymour, F Merli, C Haioun, H Ghesquieres, M Ziepert, H Tilly, G Salles, Q Shi, TC El-Galaly, TM HabermannFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.